Concepedia

João Siffert

JS

Statistics

Publications

27

Citations

2.7K

H-Index

23

Active since

1995

Affiliations

Avanir Pharmaceuticals (United States)(Current)

Mount Sinai Beth Israel

Cleveland Clinic

Rush University Medical Center

Children's & Women's Health Centre of British Columbia

João Siffert is an author at Avanir Pharmaceuticals (United States) specializing in medicine, neurology, and brain tumors.

Publications per year

1995–2018

27

Publications

27

Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial

William J. Marks, Raymond T. Bartus, João Siffert et al. · The Lancet Neurology · 2010 · 680 citations

, , +12

A phase1 study of stereotactic gene delivery of AAV2‐NGF for Alzheimer's disease

Michael S. Rafii, Tiffany Baumann, Roy A.E. Bakay et al. · Alzheimer s & Dementia · 2014 · 223 citations · Full text

, , +17

Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients

Raymond T. Bartus, Tiffany Baumann, João Siffert et al. · Neurology · 2013 · 213 citations · Full text

, , +16

Adeno-Associated Viral Vector (Serotype 2)–Nerve Growth Factor for Patients With Alzheimer Disease

Michael S. Rafii, Mark H. Tuszynski, Ronald G. Thomas et al. · JAMA Neurology · 2018 · 209 citations · Full text

, , +17

Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia

Jeffrey L. Cummings, Constantine G. Lyketsos, Elaine R. Peskind et al. · JAMA · 2015 · 201 citations

, , +17

1–5 of 27